Hikma appoints Riad Mishlawi as CEO
Hikma Pharmaceuticals said Riad Mishlawi, president of the group's injectables business, has been appointed chief executive Officer, effective from September 1.
Said Darwazah will step down as acting CEO and return to his role as executive chairman.